B. Raposo

Regulation of lysyl oxidase in vascular cells: lysyl oxidase as a new player in cardiovascular diseases.

L. Badimón, J. Martínez-González, C. Rodríguez, 2008, Cardiovascular research.

Modulation of ERG25 expression by LDL in vascular cells.

G. Vilahur, L. Badimón, V. Llorente‐Cortés, 2003, Cardiovascular research.

High levels of homocysteine inhibit lysyl oxidase (LOX) and downregulate LOX expression in vascular endothelial cells.

L. Badimón, J. Martínez-González, C. Rodríguez, 2004, Atherosclerosis.

Low Density Lipoproteins Downregulate Lysyl Oxidase in Vascular Endothelial Cells and the Arterial Wall

L. Badimón, L. Casaní, J. Martínez-González, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.

L. Badimón, J. Martínez-González, C. Rodríguez, 2009, Cardiovascular research.

Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction

L. Badimón, M. Navarro, J. Martínez-González, 2008 .

Niveles elevados de homocisteína inhiben la lisil oxidasa (LOX) y reducen la expresión de LOX en células endoteliales vasculares

L. Badimón, C. Rodríguez, B. Raposo, 2006 .

Lysyl oxidase (LOX) down-regulation by TNFalpha: a new mechanism underlying TNFalpha-induced endothelial dysfunction.

L. Badimón, M. Navarro, J. Martínez-González, 2008, Atherosclerosis.

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibition Prevents Endothelial NO Synthase Downregulation by Atherogenic Levels of Native LDLs: Balance Between Transcriptional and Posttranscriptional Regulation

L. Badimón, J. Martínez-González, C. Rodríguez, 2001, Arteriosclerosis, thrombosis, and vascular biology.